Cochlear Ltd

COH: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$969.00DtgVydyxdwzl

Cochlear Earnings: Shares Remain Overvalued, With Earnings Growth Poised to Decelerate

Wide-moat Cochlear reported fiscal 2024 sales of AUD 2.3 billion and underlying net profit after tax, or NPAT, of AUD 387 million, up 12% and 15% in constant currency, respectively, 2% below our expectations on average. While implant units sold in developed markets grew strongly on increasing adult referral rates, units sold in emerging markets declined in the second half. This was largely due to the 2024 elections in India affecting the timing of tenders. In addition, second-half services revenue moderated more than we expected, down 5% in constant currency.

Sponsor Center